Attention-deficit/hyperactivity disorder and substance abuse

Pediatrics

Volumn 134, Issue 1, 2014, Pages

  Harstad, Elizabeth ^c   Levy, Sharon ^c   Ammerman, Seth D ^c   Gonzalez, Pamela K ^c   Ryan, Sheryl A ^c   Siqueira, Lorena M ^c   Smith, Vincent C ^c   Faden, Vivian B ^a   Tau, Gregory ^b   Jarrett, Renee ^c   Baumberger, James ^c   Crumley, Katie ^c  

^a National Institute of Alcohol Abuse and Alcoholism   (United States)

^b American Academy of Child and Adolescent Psychiatry   (United States)

^c NONE

Author keywords

ADHD; Attention deficit hyperactivity disorder; Nonstimulant medication; Safe prescribing; Stimulant medication; Substance abuse

Indexed keywords

AMPHETAMINE PLUS DEXAMPHETAMINE; ATOMOXETINE; CLONIDINE; DEXAMPHETAMINE; DEXEDRINE SPANSULEA; DEXMETHYLPHENIDATE; GUANFACINE; LISDEXAMFETAMINE; METHYLPHENIDATE; PLACEBO; PROCENTRA; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ANTICIPATION; ARTICLE; ATTENTION DEFICIT DISORDER; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DISEASE SURVEILLANCE; DRUG SAFETY; ENVIRONMENTAL FACTOR; HIGH RISK PATIENT; HUMAN; MEDICAL DOCUMENTATION; PRESCRIPTION; PRIORITY JOURNAL; RISK REDUCTION; SUBSTANCE ABUSE;

ADHD; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NONSTIMULANT MEDICATION; SAFE PRESCRIBING; STIMULANT MEDICATION; SUBSTANCE ABUSE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; HUMANS; MENTAL DISORDERS; PRACTICE GUIDELINES AS TOPIC; SUBSTANCE-RELATED DISORDERS;

EID: 84904191407     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-0992     Document Type: Article

References (81)

1. Barbaresi W, Katusic S, Colligan R, et al. How common is attention-deficit/hyperactivity disorder? Towards resolution of the controversy: results from a population-based study. Acta Paediatr Suppl. 2004;93(445):55-59 (Pubitemid 38570259)
2. Centers for Disease Control and Prevention (CDC). Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children - United States, 2003 and 2007. MMWR Morb Mortal Wkly Rep. 2010;59(44):1439-1443
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Arlington, VA: American Psychiatric Publishing; 2013
4. Wolraich M, Brown L, Brown RT, et al Subcommittee on Attention-Deficit/ Hyperactivity Disorder; Steering Committee on Quality Improvement and Management. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007-1022
5. Yoshimasu K, Barbaresi WJ, Colligan RC, et al. Childhood ADHD is strongly associated with a broad range of psychiatric disorders during adolescence: a population-based birth cohort study. J Child Psychol Psychiatry. 2012;53(10):1036-1043
6. Larson K, Russ SA, Kahn RS, Halfon N. Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007. Pediatrics. 2011;127(3):462-470
7. Katusic SK, Barbaresi WJ, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ. Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study. J Child Adolesc Psychopharmacol. 2005;15(5):764-776 (Pubitemid 41567148)
8. Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003;111(1):179-185 (Pubitemid 36071051)
9. Molina BS, Hinshaw SP, Eugene Arnold L, et al; MTA Cooperative Group. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry. 2013;52(3):250-263
10. Harty SC, Ivanov I, Newcorn JH, Halperin JM. The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood. J Child Adolesc Psychopharmacol. 2011;21(4):331-339
11. Sepúlveda DR, Thomas LM, McCabe SE, Cranford JA, Boyd CJ, Teter CJ. Misuse of prescribed stimulant medication for ADHD and associated patterns of substance use: preliminary analysis among college students. J Pharm Pract. 2011;24(6):551-560
12. Rabiner DL. Stimulant prescription cautions: addressing misuse, diversion and malingering. Curr Psychiatry Rep. 2013;15(7):375
13. Kaye S, Darke S. The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care? Addiction. 2012;107(3):467-477
14. Lee SS, Humphreys KL, Flory K, Liu R, Glass K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev. 2011;31(3):328-341
15. Molina BS, Flory K, Hinshaw SP, et al. Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry. 2007;46(8):1028-1040 (Pubitemid 47220685)
16. Wilens TE, Morrison NR. Substance-use disorders in adolescents and adults with ADHD: focus on treatment. Neuropsychiatry (London). 2012;2(4):301-312
17. Horner BR, Scheibe KE. Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse. J Am Acad Child Adolesc Psychiatry. 1997;36(1):30-36 (Pubitemid 27024225)
18. Arias AJ, Gelernter J, Chan G, et al. Correlates of co-occurring ADHD in drugdependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav. 2008;33(9):1199-1207
19. Wilens TE, Martelon M, Joshi G, et al. Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. J Am Acad Child Adolesc Psychiatry. 2011;50(6):543-553
20. Brook DW, Brook JS, Zhang C, Koppel J. Association between attention-deficit/hyperactivity disorder in adolescence and substance use disorders in adulthood. Arch Pediatr Adolesc Med. 2010;164(10):930-934
21. Gudjonsson GH, Sigurdsson JF, Sigfusdottir ID, Young S. An epidemiological study of ADHD symptoms among young persons and the relationship with cigarette smoking, alcohol consumption and illicit drug use. J Child Psychol Psychiatry. 2012;53(3):304-312
22. Ernst M, Luckenbaugh DA, Moolchan ET, et al. Behavioral predictors of substanceuse initiation in adolescents with and without attention-deficit/ hyperactivity disorder. Pediatrics. 2006;117(6):2030-2039 (Pubitemid 46071248)
23. Chang Z, Lichtenstein P, Larsson H. The effects of childhood ADHD symptoms on early-onset substance use: a Swedish twin study. J Abnorm Child Psychol. 2012;40(3):425-435
24. Tamm L, Adinoff B, Nakonezny PA, Winhusen T, Riggs P. Attention-deficit/hyperactivity disorder subtypes in adolescents with comorbid substance-use disorder. Am J Drug Alcohol Abuse. 2012;38(1):93-100
25. Glass K, Flory K. Are symptoms of ADHD related to substance use among college students? Psychol Addict Behav. 2012;26(1):124-132
26. Molina BS, Pelham WE Jr. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol. 2003;112(3):497-507 (Pubitemid 36959375)
27. Whelan R, Conrod PJ, Poline JB, et al IMAGEN Consortium. Adolescent impulsivity phenotypes characterized by distinct brain networks. Nat Neurosci. 2012;15(6):920-925
28. Wilens TE, Biederman J. Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth. J Psychopharmacol. 2006;20(4):580-588 (Pubitemid 43875189)
29. Wilens TE, Martelon M, Fried R, Petty C, Bateman C, Biederman J. Do executive function deficits predict later substance use disorders among adolescents and young adults? J Am Acad Child Adolesc Psychiatry. 2011;50(2):141-149
30. Volkow ND, Wang GJ, Fowler JS, Ding YS. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/ hyperactivity disorder. Biol Psychiatry. 2005;57(11):1410- 1415 (Pubitemid 40798562)
31. Volkow ND, Wang GJ, Kollins SH, et al. Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA. 2009;302(10):1084-1091
32. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005;162(8):1403-1413 (Pubitemid 41105554)
33. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet. 1999;354(9196):2132-2133 (Pubitemid 30008900)
34. Cavacuiti C; American Society of Addiction Medicine. Principles of Addiction Medicine: The Essentials. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011
35. Greenhill LL, Halperin JM, Abikoff H. Stimulant medications. J Am Acad Child Adolesc Psychiatry. 1999;38(5):503-512 (Pubitemid 29203465)
36. Wilens TE, Adamson J, Sgambati S, et al. Do individuals with ADHD self-medicate with cigarettes and substances of abuse? Results from a controlled family study of ADHD. Am J Addict. 2007;16(suppl 1):14-21; quiz 22-23
37. Edwards AC, Kendler KS. Twin study of the relationship between adolescent attentiondeficit/hyperactivity disorder and adult alcohol dependence. J Stud Alcohol Drugs. 2012;73(2):185-194
38. Biederman J, Petty CR, Wilens TE, et al. Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders. Am J Psychiatry. 2008;165(1):107-115 (Pubitemid 351704559)
39. Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Jacobsen SJ. Long-term school outcomes for children with attentiondeficit/hyperactivity disorder: a population-based perspective. J Dev Behav Pediatr. 2007;28(4):265-273 (Pubitemid 47256029)
40. Bussing R, Mason DM, Bell L, Porter P, Garvan C. Adolescent outcomes of childhood attention-deficit/hyperactivity disorder in a diverse community sample. J Am Acad Child Adolesc Psychiatry. 2010;49(6):595-605
41. Fletcher A, Bonell C, Sorhaindo A, Strange V. How might schools influence young people's drug use? Development of theory from qualitative case-study research. J Adolesc Health. 2009;45(2):126-132
42. Trenz RC, Harrell P, Scherer M, Mancha BE, Latimer WW. A model of school problems, academic failure, alcohol initiation, and the relationship to adult heroin injection. Subst Use Misuse. 2012;47(10):1159-1171
43. Donath C, Grässel E, Baier D, Pfeiffer C, Bleich S, Hillemacher T. Predictors of binge drinking in adolescents: ultimate and distal factors - a representative study. BMC Public Health. 2012;12:263
44. Wilens TE, Adamson J, Monuteaux MC, et al. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc Med. 2008;162(10):916-921
45. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of attentiondeficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics. 1999;104(2). Available at: www.pediatrics.org/cgi/content/full/104/ 2/e20
46. Mannuzza S, Klein RG, Truong NL, et al. Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. Am J Psychiatry. 2008;165(5):604-609 (Pubitemid 351705337)
47. Murray DW, Arnold LE, Swanson J, et al. A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA). Curr Psychiatry Rep. 2008;10(5):424-431
48. Barbaresi WJ, Colligan RC, Weaver AL, Voigt RG, Killian JM, Katusic SK. Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study. Pediatrics. 2013;131(4):637-644
49. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36(2):159-165 (Pubitemid 43126140)
50. Warden D, Riggs PD, Min SJ, et al. Major depression and treatment response in adolescents with ADHD and substance use disorder. Drug Alcohol Depend. 2012;120(1-3):214-219
51. Sartor CE, Lynskey MT, Heath AC, Jacob T, True W. The role of childhood risk factors in initiation of alcohol use and progression to alcohol dependence. Addiction. 2007;102(2):216-225 (Pubitemid 46096282)
52. Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Jacobsen SJ. Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study. J Dev Behav Pediatr. 2007;28(4):274-287 (Pubitemid 47256030)
53. Setlik J, Bond GR, Ho M. Adolescent prescription ADHD medication abuse is rising along with prescriptions for these medications. Pediatrics. 2009;124(3):875-880
54. Wilens TE, Adler LA, Adams J, et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47(1):21-31
55. Arria AM, Caldeira KM, O'Grady KE, Vincent KB, Johnson EP, Wish ED. Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use. Pharmacotherapy. 2008;28(2):156-169 (Pubitemid 351206963)
56. White BP, Becker-Blease KA, Grace-Bishop K. Stimulant medication use, misuse, and abuse in an undergraduate and graduate student sample. J Am Coll Health. 2006;54(5):261-268
57. Teter CJ, McCabe SE, LaGrange K, Cranford JA, Boyd CJ. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy. 2006;26(10):1501-1510 (Pubitemid 44521735)
58. Boyd CJ, McCabe SE, Cranford JA, Young A. Adolescents' motivations to abuse prescription medications. Pediatrics. 2006;118(6):2472-2480 (Pubitemid 46397588)
59. Kollins SH. Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD). Am J Addict. 2007;16(suppl 1):35-42; quiz 43-44
60. Musser CJ, Ahmann PA, Theye FW, Mundt P, Broste SK, Mueller-Rizner N. Stimulant use and the potential for abuse in Wisconsin as reported by school administrators and longitudinally followed children. J Dev Behav Pediatr. 1998;19(3):187-192 (Pubitemid 128456246)
61. McCabe SE, Teter CJ, Boyd CJ. The use, misuse and diversion of prescription stimulants among middle and high school students. Subst Use Misuse. 2004;39(7):1095-1116 (Pubitemid 39163121)
62. Aldridge AP, Kroutil LA, Cowell AJ, Reeves DB, Van Brunt DL. Medication costs to private insurers of diversion of medications for attention-deficit hyperactivity disorder. Pharmacoeconomics. 2011;29(7):621-635
63. Novak SP, Kroutil LA, Williams RL, Van Brunt DL. The nonmedical use of prescription ADHD medications: results from a national Internet panel. Subst Abuse Treat Prev Policy. 2007;2:32
64. Wilens TE, Gignac M, Swezey A, Monuteaux MC, Biederman J. Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. J Am Acad Child Adolesc Psychiatry. 2006;45(4):408-414 (Pubitemid 43675545)
65. DeSantis AD, Webb EM, Noar SM. Illicit use of prescription ADHD medications on a college campus: a multimethodological approach. J Am Coll Health. 2008;57(3):315-324
66. Smith RC, Davis JM. Comparative effects of d-amphetamine, l-amphetamine, and methylphenidate on mood in man. Psychopharmacology (Berl). 1977;53(1):1-12 (Pubitemid 8119909)
67. Kollins SH, Shapiro SK, Newland MC, Abramowitz A. Discriminative and participant-rated effects of methylphenidate in children diagnosed with attention deficit hyperactivity disorder (ADHD). Exp Clin Psychopharmacol. 1998;6(4):375-389 (Pubitemid 29001515)
68. Fredericks EM, Kollins SH. Assessing methylphenidate preference in ADHD patients using a choice procedure. Psychopharmacology (Berl). 2004;175(4):391-398 (Pubitemid 39362036)
69. Kollins SH, Rush CR, Pazzaglia PJ, Ali JA. Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate. Exp Clin Psychopharmacol. 1998;6(4):367-374 (Pubitemid 29001514)
70. Bright GM. Abuse of medications employed for the treatment of ADHD: results from a large-scale community survey. Medscape J Med. 2008;10(5):111
71. Mao AR, Babcock T, Brams M. ADHD in adults: current treatment trends with consideration of abuse potential of medications. J Psychiatr Pract. 2011;17(4):241-250
72. Carroll BC, McLaughlin TJ, Blake DR. Patterns and knowledge of nonmedical use of stimulants among college students. Arch Pediatr Adolesc Med. 2006;160(5):481-485
73. Collett BR, Ohan JL, Myers KM. Ten-year review of rating scales. V: scales assessing attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2003;42(9):1015-1037 (Pubitemid 39571825)
74. Levy SJ, Kokotailo PK; Committee on Substance Abuse. Substance use screening, brief intervention, and referral to treatment for pediatricians. Pediatrics. 2011;128 (5). Available at: www.pediatrics.org/cgi/content/full/128/ 5/e1330
75. National Institute of Health, Office of Extramural Research. Grants & funding, funding opportunities & notices search results, April 22, 2011. Available at: http://grants1.nih.gov/grants/guide/search-results.htm?text-curr= niaaa&scope=rfa&year=active&sort=rel&text-prev=&Search.x= 26&Search.y=4. Accessed November 13, 2012
76. National Institute on Drug Abuse (NIDA). Funding application-request for applications. Available at: www.drugabuse.gov/funding-app/rfa. Accessed November 13, 2012
77. Dupont RL, Coleman JJ, Bucher RH, Wilford BB. Characteristics and motives of college students who engage in nonmedical use of methylphenidate. Am J Addict. 2008;17(3):167-171 (Pubitemid 351883180)
78. Mariani JJ, Levin FR. Treatment strategies for co-occurring ADHD and substance use disorders. Am J Addict. 2007;16(suppl 1):45-54; quiz 55-56
79. Faraone SV, Glatt SJ. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry. 2010;71(6):754-763
80. Jasinski DR, Krishnan S. Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse. J Psychopharmacol. 2009;23(4):419-427
81. Elbe D, Macbride A, Reddy D. Focus on lisdexamfetamine: a review of its use in child and adolescent psychiatry. J Can Acad Child Adolesc Psychiatry. 2010;19(4):303-314